FDA found Salmonella in Acme Smoked Fish’s ready-to-eat cold smoked tuna and Listeria in the Brooklyn plant, citing seafood safety plan and sanitation failures.
What happened
FDA inspected the Brooklyn facility on January 6, 7, 11, 13, 19-21, 25, 26, 29 and February 10, 2021, and collected finished-product and environmental samples. FDA found Salmonella in two of 11 samples of ready-to-eat cold smoked tuna that were on hold, and found Listeria monocytogenes in one environmental swab. FDA also cited seafood HACCP (seafood safety plan) and CGMP (current good manufacturing practice) violations, including inadequate corrective actions and missing thawing controls.
What FDA found
Ready-to-eat cold smoked tuna contained Salmonella, and an environmental swab from the facility was positive for Listeria monocytogenes.
Federal Food, Drug, and Cosmetic Act section 402(a)(4), 21 U.S.C. § 342(a)(4)The company's corrective actions after its own Salmonella-positive tuna tests did not fix the cause or check whether other affected lots entered commerce.
21 CFR 123.7 and 123.8(b)The seafood safety plan (HACCP) for cold smoked fish did not include a thawing step to control pathogen growth and toxin formation, a repeat finding.
21 CFR 123.6(a) and (c)(2)The company did not monitor processing closely enough to prevent cross-contamination, including ready-to-eat cold smoked products passing through a room where raw fish was being cut.
21 CFR 123.11(b) and 21 CFR 117.80(c)(6)
What FDA wants
FDA tells the company to correct the HACCP and sanitation failures and to respond with a revised supplier approval program, raw-material testing records, the raw-tuna supplier’s HACCP and sanitation procedures, and a revised HACCP plan with thawing controls; the excerpt does not state a response deadline.
Who should pay attention
- retailers and restaurants that sell or serve ready-to-eat smoked seafood
- brands that buy smoked seafood or use it as an ingredient
- food safety teams at seafood processors with cold-smoked or ready-to-eat products
This is a summary. Read the original letter on fda.gov.